Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota

Applied and Environmental Microbiology

Volumn 72, Issue 10, 2006, Pages 6707-6715

  Dalby, Andrew B ^a   Frank, Daniel N ^a   St Amand, Allison L ^a   Bendele, Alison M ^a   Pace, Norman R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DATA REDUCTION; DRUG PRODUCTS; GENES; MICROBIOLOGY; RNA;

INFLAMMATORY CONDITIONS; MESENTERIC LYMPH NODES; NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS);

LIVING SYSTEMS STUDIES;

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

BACTERIUM; BIOTA; DIGESTIVE SYSTEM; DIGESTIVE SYSTEM DISORDER; DRUG; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENETICS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG INDUCED DISEASE; ENTEROCOCCUS FAECALIS; FEMALE; GENE LIBRARY; INTESTINE FLORA; MESENTERY LYMPH NODE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RAT; RNA ANALYSIS; SMALL INTESTINE; SPECIES DIFFERENCE; STOMACH IRRITATION; ULCER;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ECOSYSTEM; ENTEROCOCCUS FAECALIS; FEMALE; GASTROINTESTINAL DISEASES; INDOMETHACIN; INTESTINE, SMALL; MOLECULAR SEQUENCE DATA; PEPTIC ULCER; RATS; RATS, INBRED LEW;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS;

EID: 33750077286     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.00378-06     Document Type: Article

References (47)

1. Backhed, F., R. E. Ley, J. L. Sonnenburg, D. A. Peterson, and J. I. Gordon. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915-1920.
2. Brooks, S. P., M. McAllister, M. Sandoz, and M. L. Kalmokoff. 2003. Culture-independent phylogenetic analysis of the faecal flora of the rat. Can. J. Microbiol. 49:589-601.
3. Caldwell, B., S. Aldington, M. Weatherall, P. Shirtcliffe, and R. Beasley. 2006. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J. R. Soc. Med. 99:132-140.
4. Dojka, M. A., P. Hugenholtz, S. K. Haack, and N. R. Pace. 1998. Microbial diversity in a hydrocarbon- and chlorinated-solvent-contaminated aquifer undergoing intrinsic bioremediation. Appl. Environ. Microbiol. 64:3869-3877.
5. Don, R. H., P. T. Cox, B. J. Wainwright, K. Baker, and J. S. Mattick. 1991. Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19:4008.
6. Eckburg, P. B., E. M. Bik, C. N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S. R. Gill, K. E. Nelson, and D. A. Relman. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-1638.
7. Evans, S. M., and B. J. Whittle. 2003. Role of bacteria and inducible nitric oxide synthase activity in the systemic inflammatory microvascular response provoked by indomethacin in the rat. Eur. J. Pharmacol. 461:63-71.
8. Fang, W. F., A. Broughton, and E. D. Jacobson. 1977. Indomethacin-induced intestinal inflammation. Am. J. Dig. Dis. 22:749-760.
9. Frank, D. N., and N. R. Pace. 2001. Molecular-phylogenetic analyses of human gastrointestinal microbiota. Curr. Opin. Gastroenterol. 17:52-57.
10. Frank, D. N., G. B. Splegelman, W. Davis, E. Wagner, E. Lyons, and N. R. Pace. 2003. Culture-independent molecular analysis of microbial constituents of the healthy human outer ear. J. Clin. Microbiol. 41:295-303.
11. Graham, D. J., D. Campen, R. Hui, M. Spence, C. Cheetham, G. Levy, S. Shoor, and W. A. Ray. 2005. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365:475-481.
12. Graham, D. Y., A. R. Opekun, F. F. Willingham, and W. A. Qureshi. 2005. Visible small-intestinal mucosal injury in chronic NSAID users. Clin. Gastroenterol. Hepatol. 3:55-59.
13. Harmsen, H. J., G. R. Gibson, P. Elfferich, G. C. Raangs, A. C. Wildeboer-Veloo, A. Argaiz, M. B. Roberfroid, and G. W. Welling. 2000. Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol. Lett. 183:125-129.
14. Hippisley-Cox, J., and C. Coupland. 2005. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 330:1366.
15. Hippisley-Cox, J., C. Coupland, and R. Logan. 2005. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 331:1310-1316.
16. Kemp, P. F., and J. Y. Aller. 2004. Bacterial diversity in aquatic and other environments: what 16S rDNA libraries can tell us. FEMS Microbiol. Ecol. 47:161-177.
17. Kent, T. H., R. M. Cardelli, and F. W. Stamler. 1969. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am. J. Pathol. 54:237-249.
18. Lane, D. J. 1991. 16S/23S rRNA sequencing, p. 115-175. In S. A. M. Goodfellow (ed.), Nucleic acid techniques in bacterial systematics. John Wiley & Sons, Inc., New York, N.Y.
19. Leser, T. D., J. Z. Amenuvor, T. K. Jensen, R. H. Lindecrona, M. Boye, and K. Moller. 2002. Culture-independent analysis of gut bacteria: the pig gastrointestinal tract microbiota revisited. Appl. Environ. Microbiol. 68:673-690.
20. Ley, R. E., F. Backhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102:11070-11075.
21. Ley, R. E., J. K. Harris, J. Wilcox, J. R. Spear, S. R. Miller, B. M. Bebout, J. A. Maresca, D. A. Bryant, M. L. Sogin, and N. R. Pace. 2006. Unexpected diversity and complexity of the Guerrero Negro hypersaline microbial mat. Appl. Environ. Microbiol. 72:3685-3695.
22. Mahida, Y. R., and V. E. Rolfe. 2004. Host-bacterial interactions in inflammatory bowel disease. Clin. Sci. (London) 107:331-341.
23. Maidak, B. L., J. R. Cole, C. T. Parker, Jr., G. M. Garrity, N. Larsen, B. Li, T. G. Lilburn, M. J. McCaughey, G. J. Olsen, R. Overbeek, S. Pramanik, T. M. Schmidt, J. M. Tiedje, and C. R. Woese. 1999. A new version of the RDP (Ribosomal Database Project). Nucleic Acids Res. 27:171-173.
24. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
25. Meyerholz, D. K., T. J. Stabel, and N. F. Cheville. 2002. Segmented filamentous bacteria interact with intraepithelial mononuclear cells. Infect. Immun. 70:3277-3280.
26. Ott, S. J., M. Musfeldt, D. F. Wenderoth, J. Hampe, O. Brant, U. R. Folsch, K. N. Timmis, and S. Schreiber. 2004. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53:685-693.
27. Pace, N. R. 1997. A molecular view of microbial diversity and the biosphere. Science 276:734-740.
28. Papineau, D., J. J. Walker, S. J. Mojzsis, and N. R. Pace. 2005. Composition and structure of microbial communities from stromatolites of Hamelin Pool in Shark Bay, Western Australia. Appl. Environ. Microbiol. 71:4822-4832.
29. Pryde, S. E., A. J. Richardson, C. S. Stewart, and H. J. Flint. 1999. Molecular analysis of the microbial diversity present in the colonic wall, colonic lumen, and cecal lumen of a pig. Appl. Environ. Microbiol. 65:5372-5377.
30. Rappe, M. S., and S. J. Giovannoni. 2003. The uncultured microbial majority. Annu. Rev. Microbiol. 57:369-394.
31. R Development Core Team. 2005. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
32. Robert, A., and T. Asano. 1977. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins 14:333-341.
33. Ruiz, P. A., A. Shkoda, S. C. Kim, R. B. Sartor, and D. Haller. 2005. IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J. Immunol. 174:2990-2999.
34. Sarma-Rupavtarm, R. B., Z. Ge, D. B. Schauer, J. G. Fox, and M. F. Polz. 2004. Spatial distribution and stability of the eight microbial species of the altered schaedler flora in the mouse gastrointestinal tract. Appl. Environ. Microbiol. 70:2791-2800.
35. Schloss, P. D., and J. Handelsman. 2004. Status of the microbial census. Microbiol. Mol. Biol. Rev. 68:686-691.
36. Silverstein, F. E., G. Faich, J. L. Goldstein, L. S. Simon, T. Pincus, A. Whelton, R. Makuch, G. Eisen, N. M. Agrawal, W. F. Stenson, A. M. Burr, W. W. Zhao, J. D. Kent, J. B. Letkowith, K. M. Verburg, and G. S. Geis. 2000. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284:1247-1255.
37. Sonnenburg, J. L., L. T. Angenent, and J. I. Gordon. 2004. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat. Immunol. 5:569-573.
38. Spear, J. R., J. J. Walker, T. M. McCollom, and N. R. Pace. 2005. Hydrogen and bioenergetics in the Yellowstone geothermal ecosystem. Proc. Natl. Acad. Sci. USA 102:2555-2560.
39. Stackebrandt, E., and B. M. Goebel. 1994. Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology. Int. J. Syst. Bacteriol. 44:846-849.
40. Suau, A., R. Bonnet, M. Sutren, J. J. Godon, G. R. Gibson, M. D. Collins, and J. Dore. 1999. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 65:4799-4807.
41. Umesaki, Y., H. Setoyama, S. Matsumoto, A. Imaoka, and K. Itoh. 1999. Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system. Infect. Immun. 67:3504-3511.
42. Voth, D. E., and J. D. Ballard. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247-263.
43. Walker, J. J., J. R. Spear, and N. R. Pace. 2005. Geobiology of a microbial endolithic community in the Yellowstone geothermal environment. Nature 434:1011-1014.
44. Whittle, B. J. 2004. Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors. Eur. J. Pharmacol. 500:427-439.
45. Wilson, K. H., and R. B. Blitchington. 1996. Human colonic biota studied by ribosomal DNA sequence analysis. Appl. Environ. Microbiol. 62:2273-2278.
46. Wolfe, M. M., D. R. Lichtenstein, and G. Singh. 1999. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 340:1888-1899.
47. Yamada, T., E. Deitch, R. D. Specian, M. A. Perry, R. B. Sartor, and M. B. Grisham. 1993. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17:641-662.